Back to Authors

Gutmann, Laurie

0000-0003-3926-4209

Mayo Clinic

From the Department of Neurology (N.B., C.J.B., E.A.C.), Mayo Clinic, Rochester, MN; Pediatric Neurology (A.L.C.), Providence Health and Services, Portland, OR; and Department of Neurology (L.G.), Indiana University School of Medicine, Indianapolis.

Citations 4

The Auxiliary to the American Academy of Neurology

Neurology | February 6, 2024 | Volume: 102 | Issue: 5 | Pages: No page available

10.1212/wnl.0000000000209142 | PMID 38320220

Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke

JAMA | August 1, 2019 | Volume: 322 | Issue: 4 | Pages: 326

10.1001/jama.2019.9346 | PMID 31334795

Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine

Muscle & Nerve | December 13, 2015 | Volume: 53 | Issue: 2 | Pages: 165-168

10.1002/mus.25009 | PMID 26662952

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial

Neurology | November 24, 2008 | Volume: 71 | Issue: 22 | Pages: 1770-1775

10.1212/01.wnl.0000335970.78664.36 | PMID 19029516